Home » Intellectual Property

Patent Law Harmonization

IP: Imperative for Innovation

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

Letters, Testimony & Comments

BIO Comments on Colombia Biologics and Biosimilars Regulations
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
BIO Comments on INPI Guidelines for Examination of Patent Applications
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
International Patent Issues Highlighted at House Judiciary Committee Hearing: BIO Submits Biotech's Challenges
April 25 2012
  The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
AIA Oath or Declaration: BIO Comments
March 7 2012
Selected Excerpts: The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
2012 Special 301 Report: Biotech's International IP Issues
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
More Letters, Testimony & Comments →

Press Releases

BIO Hosts U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office and China’s State Intellectual Property Office
April 5 2011
WASHINGTON, D.C. (Tuesday, April 05, 2011) - The Biotechnology Industry Organization (BIO) hosted a U.S./China...
Director of U.S. Patent and Trademark Office to Speak at 2010 BIO International Convention
March 15 2010
WASHINGTON, D.C. (Monday, March 15, 2010) - David Kappos, Director of the U.S. Patent and Trademark Office and Under...